Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.
暂无分享,去创建一个
M. Mack | J. Bavaria | E. Tuzcu | L. Svensson | J. Moses | M. Leon | D. C. Miller | S. Kapadia | E. Blackstone | J. Webb | A. Pichard | Craig R. Smith | David L. Brown | R. Guyton | H. Herrmann | P. Block | V. Thourani | P. Généreux | G. Fontana | R. Makkar | J. Akin | V. Babaliaros | Mathew R. Williams | R. Makkar | J. Rajeswaran | N. Brozzi | D. C. Miller
[1] Samuel T. Edwards,et al. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. , 2014, The Journal of thoracic and cardiovascular surgery.
[2] B. Lytle,et al. A comprehensive review of the PARTNER trial. , 2013, Journal of Thoracic and Cardiovascular Surgery.
[3] M. Reynolds,et al. Cost-effectiveness of TAVR in the non-surgical population , 2013, Journal of medical economics.
[4] I. Barbash,et al. Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation. , 2012, The American journal of cardiology.
[5] J. Bavaria,et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. , 2012, Journal of the American College of Cardiology.
[6] Susheel Kodali,et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. , 2012, The New England journal of medicine.
[7] Scott Lim,et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.
[8] M. Mack,et al. ACQUIRED CARDIOVASCULAR DISEASE Transcatheter ( TAVR ) versus surgical ( AVR ) aortic valve replacement : Occurrence , hazard , risk factors , and consequences of neurologic events in the PARTNER trial , 2012 .
[9] J. Bavaria,et al. The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals. , 2011, The Annals of thoracic surgery.
[10] H. Schaff. Transcatheter aortic-valve implantation--at what price? , 2011, The New England journal of medicine.
[11] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[12] Gerda Claeskens,et al. Nonparametric Estimation , 2011, International Encyclopedia of Statistical Science.
[13] L. Svensson. Percutaneous aortic valves: effective in inoperable patients, what price in high-risk patients? , 2010, The Journal of thoracic and cardiovascular surgery.
[14] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[15] R. Suri. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement , 2010 .
[16] Sean M. O'Brien,et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. , 2009, The Annals of thoracic surgery.
[17] Fabian Nietlispach,et al. Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes , 2009, Circulation.
[18] M. Cheitlin. United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex , 2009 .
[19] T. Felderhoff,et al. Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System , 2008, Circulation. Cardiovascular interventions.
[20] M. Mack,et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.
[21] R. Bansal,et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. , 2006, The Annals of thoracic surgery.
[22] Thomas Felderhoff,et al. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.
[23] Christopher E. Buller,et al. Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.
[24] E. Blackstone. Outcome analysis using hazard function methodology. , 1996, The Annals of thoracic surgery.
[25] Niels Keiding,et al. Statistical Models Based on Counting Processes , 1993 .
[26] J. Kirklin. ACC/AHA guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). , 1991, Circulation.
[27] E. Blackstone,et al. The early results of treatment of simple transposition in the current era. , 1988, The Journal of thoracic and cardiovascular surgery.
[28] Malcolm E. Turner,et al. The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .
[29] E. Blackstone,et al. Death and other time-related events after valve replacement. , 1985, Circulation.
[30] B. Brundage,et al. Rate of progression of severity of valvular aortic stenosis in the adult. , 1979, American heart journal.
[31] B. Carabello,et al. Aortic stenosis , 2018, Rapid Cardiac Care.
[32] Donald Fraser,et al. Nonparametric Estimation IV , 1951 .